Abstract
Nowadays, bacterial resistance can be considered as one of the main challenges in public health. Antimicrobials available in clinical practice no longer have the effectiveness expected, and the development of new drugs is not being able to overcome the progress of multidrug-resistant bactéria - especially in regard to Gram-negative bacteria, such as Klebsiella pneumoniae and Acinetobacter…